drugset / Trial / NCT06997029
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess BMS-986500 as monotherapy in advanced solid tumors and as combination therapy in CDK4/6 inhibitor pre-treated advanced breast cancer.
Timeline
- Start
- 2025-08-01
- Primary completion
- 2028-12-14
- Completion
- 2028-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986500 | Unknown | — | — |
| Background | Fulvestrant | Small molecule | — | — |
| Background | Palbociclib | Small molecule | — | — |